SCHEMBL690093

SCHEMBL690093

CCCCCCC(CC)(C(=O)O)C(CC)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.44
BLM P54132 1/20 0.44
HSPE1 P61604 1/20 0.44
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GPR84 Q9NQS5 4/20 0.39
FFAR1 O14842 1/20 0.39
PPARD Q03181 2/20 0.38
MAPT P10636 1/20 0.38
LCK P06239 1/20 0.38
ZDHHC20 Q5W0Z9 1/20 0.38
ZDHHC2 Q9UIJ5 1/20 0.38
CES2 O00748 1/20 0.37
CA2 P00918 1/20 0.36
MAPK1 P28482 1/20 0.36
ACE2 Q9BYF1 1/20 0.36
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28501006 0.93 HSPD1 (0.39) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL1716951 0.88 HSPD1 (0.54) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL11372416 0.85 HSPD1 (0.54) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL11676251 0.83 MAPT (0.39) HSPD1BLMHSPE1HPGDRECQL
SCHEMBL1122815 0.81 HSPD1 (0.34) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL27210077 0.81 HSPD1 (0.57) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL3554641 0.80 SMPD1 (0.40) MEN1KMT2AHSD17B10GPR84FFAR1
SCHEMBL29139332 0.79 HSPD1 (0.33) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL690092 0.79 HSPD1 (0.58) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL27823774 0.79 GPR84 (0.41) GPR84FFAR1CES2ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3357485-B1 SUNSCREEN COSMETIC SHISEIDO CO LTD (JP) 2026-05-27 EP claimed
EP-3473237-B1 LIP COSMETIC SHISEIDO CO LTD (JP) 2023-04-19 EP claimed
EP-4025178-B1 NOVEL SYSTEM FOR SOLUBILISING FAT-SOLUBLE ORGANIC SUN FILTERS FABRE PIERRE DERMO COSMETIQUE (FR) 2023-01-18 EP claimed
US-20190226141-A1 BIO-BASED POLYELECTROLYTE COMPLEX COMPOSITIONS COMPRISING NON-WATER SOLUBLE PARTICLES ORGANOCLICK AB (SE) 2019-07-25 US claimed
EP-3504264-A1 BIO-BASED POLYELECTROLYTE COMPLEX COMPOSITIONS COMPRISING NON-WATER SOLUBLE PARTICLES OrganoClick AB (SE) 2019-07-03 EP claimed
WO-2018038669-A1 BIO-BASED POLYELECTROLYTE COMPLEX COMPOSITIONS COMPRISING NON-WATER SOLUBLE PARTICLES ORGANOCLICK AB (SE) 2018-03-01 WO claimed
EP-2301522-B1 WATER-IN-OIL EMULSION-TYPE COSMETIC PREPARATION SHISEIDO CO LTD (JP) 2018-02-28 EP claimed
EP-2288416-B2 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS GOJO IND INC (US) 2014-12-24 EP claimed
EP-2288416-B1 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS GOJO IND INC (US) 2012-02-29 EP claimed
US-20260015443-A1 POLYPROPLYENE COMPOSITIONS WITH ENHANCED STRAIN HARDENING AND METHODS OF PRODUCING THE SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-01-15 US disclosed
WO-2024025741-A1 POLYPROPYLENE COMPOSITIONS WITH ENHANCED STRAIN HARDENING AND METHODS OF PRODUCING SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2024-02-01 WO disclosed
EP-3580275-B1 HIGH MELT STRENGTH POLYPROPYLENES WITH IMPROVED PROCESSABILITY EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-07-19 EP disclosed
US-20230077569-A1 PROPYLENE-BASED POLYMER COMPOSITIONS HAVING A HIGH MOLECULAR WEIGHT TAIL EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-03-16 US disclosed
US-11572462-B2 High melt strength polypropylenes with improved processability EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-02-07 US disclosed
WO-2011082910-A2 TWO-PHASE DEVELOPER HENKEL AG & CO. KGAA (DE) 2011-07-14 WO disclosed
US-20100240704-A1 METHOD OF MODULATING STRESS-ACTIVATED PROTEIN KINASE SYSTEM INTERMUNE, INC. 2010-09-23 US disclosed
US-7728013-B2 Method of modulating stress-activated protein kinase system INTERMUNE, INC. (US) 2010-06-01 US disclosed
US-20060270612-A1 Method of modulating stress-activated protein kinase system INTERMUNE, INC. 2006-11-30 US disclosed
EP-0497706-B1 Thermoformable compositions, process for preparing them and their use for obtaining thermoformed articles ROQUETTE FRERES (FR) 1996-11-13 EP disclosed
EP-0497706-A1 Thermoformable compositions, process for preparing them and their use for obtaining thermoformed articles Roquette Frˬres (FR) 1992-08-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015443-A1 POLYPROPLYENE COMPOSITIONS WITH ENHANCED STRAIN HARDENING AND METHODS OF PRODUCING THE SAME PFN1, PSD, FDFT1 HSPD1 251/4885BLM 1190/4885HSPE1 562/4885
US-20100240704-A1 METHOD OF MODULATING STRESS-ACTIVATED PROTEIN KINASE SYSTEM MAPKAPK2, MAP3K6, MAP4K1 HSPD1 331/4885BLM 4278/4885HSPE1 340/4885
US-20060270612-A1 Method of modulating stress-activated protein kinase system MAPKAPK2, MAP3K6, MAP4K1 HSPD1 331/4885BLM 4278/4885HSPE1 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.